September 25th, 2013. Manhattan. During the month of October the New York Vein Treatment Center will run a campaign on the risk factors associated with Deep Vein Thrombosis (DVT). According to the Manhattan-based vein center, an estimated 300,000 to 600,000 Americans are affected by DVT, condition during which blood clots form in the veins of the lower extremities. The center plans to provide information that will help individuals take steps to lower their DVT risk, resulting in a lower rate of its incidence.
According to Dr. Lev Khitin, a leading vein doctor at the New York Vein Treatment Center, lack of movement is a common risk factor for DVT. “Individuals who spend extended amount of time sitting or standing in the same position, such as during a long trip in a plane or car, have a greater risk of DVT. Wearing compression stockings can help to reduce this risk by encouraging proper circulation.”
The New York Vein Treatment Center will be utilizing social media to help distribute information about DVT risk factors. Interested individuals can learn more by visiting the center’s Facebook and Twitter pages.
For more information, visit:
Varicose Vein Treatment Options
Varicose veins and spider veins are extremely common in men and women. While spider veins are very small, reddish veins on the surface of the skin, varicose veins are much larger, bulging, tangled veins that may appear bluish in color. Men and women suffer from varicose veins, although women are much more likely to have them.
Today, patients have access to a number of effective varicose vein treatment options. Advancements in technology and medicine have led to the development of safe, effective, minimally invasive treatment modalities that provide excellent, most importantly permanent results with no side-effects or downtime. Some of these modalities are foam- sclerotherapy and cryo-sclero, radio-frequency ablation, micro-phlebectomy, endovenous LASER obliteration and many others.
About New York Vein Treatment Center
The New York Vein Treatment Center (NYVTC) was established in 2002 as a medical facility devoted exclusively to the treatment of varicose veins, spider veins, and related venous disorders. The NYVTC is the most comprehensive treatment center in New York, with the latest techniques and state-of-the-art equipment for the diagnosis and treatment of venous diseases. Sclerotherapy, cryo sclerotherapy, foam and duplex-guided sclerotherapy, LASER therapy, micro-phlebectomy, TIGO®, EndoLASER®, ClariVein® obliteration, Trellis® thrombectomy and lysis are only some of multiple therapeutic modalities currently employed by NYVTC.
The founder, president, and leading physician of the NYVTC Dr. Lev M. Khitin is a well-known and respected surgeon, board-certified in cardiac, general, thoracic, and vascular surgery, a Fellow of the American College of Surgeons, a member of American College of Cardio-Vascular Surgery and of American College of Cardiology and a Fellow of American Society of Phlebology and American College of Phlebology among many other professional societies and organizations.
New York Vein Treatment Center